Designer Babies are No Longer Science Fiction: What are The Ethical Considerations?
Article Sidebar
Main Article Content
Abstract
Designer babies, a concept once relegated to science fiction, are now a burgeoning topic of discussion and exploration in genetics and bioethics. This paper provides a comprehensive overview of the designer baby phenomenon, examining its definition and evolution from cinematic fantasy to scientific possibility. We delve into the intricate mechanisms behind designer babies, shedding light on the genetic engineering technologies, particularly CRISPR, that underpin this concept. While these technologies hold immense promise, they are still nascent, awaiting rigorous development and ethical scrutiny. The paper highlights the current state of designer baby research, emphasising that successful implementations on human subjects remained unverified as of its writing. Notably, we recount the controversial case of He Jiankui, whose unapproved and ethically questionable experimentation with CRISPR on embryos in China sent shockwaves through the scientific community. The arguments surrounding designer babies are dissected, presenting both proponents' views, such as the potential to eradicate genetic diseases and enhance human potential, and critics' concerns about ethical dilemmas, reduced genetic diversity, social inequality, and unpredictable consequences. Ethical considerations are paramount, touching upon human dignity, social justice, eugenics, unintended consequences, autonomy, and the impact on religious and moral convictions. Once a fantastical notion, designer babies have become a tangible subject of scientific inquiry and ethical discourse. This paper endeavours to provide a comprehensive understanding of the multifaceted dimensions surrounding designer babies, allowing readers to contemplate the ethical, social, and scientific implications of a future where genetic engineering may shape the very essence of human existence. As society grapples with these profound questions, we must navigate this uncharted territory with wisdom, responsibility, and an unwavering commitment to ethical principles.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Accepted 2023-10-05
Published 2023-10-19
Plaudit
References
Pang, R. T., & Ho, P. C. (2016). Designer babies. Obstetrics, Gynaecology & Reproductive Medicine, 26(2), 59-60. DOI: https://doi.org/10.1016/j.ogrm.2015.11.011
Suter, S. M. (2007). A brave new world of designer babies. Berkeley Tech. LJ, 22, 897. DOI: https://doi.org/10.1215/08879982-2007-5015
Handyside, A. H. (2018). ‘Designer babies’ almost thirty years on. Reproduction, 156(1), F75-F79. DOI: https://doi.org/10.1530/REP-18-0157
Pieczynski, J. N., & Kee, H. L. (2021). “Designer babies?!” A CRISPR‐based learning module for undergraduates built around the CCR5 gene. Biochemistry and Molecular Biology Education, 49(1), 80-93.
Ledford, H. (2017). CRISPR fixes disease genes in viable human embryos. Nature, 548(7665), 13-14. DOI: https://doi.org/10.1038/nature.2017.22382
Khalil, A. M. (2020). The genome editing revolution. Journal of genetic engineering and biotechnology, 18(1), 1-16. DOI: https://doi.org/10.1186/s43141-020-00078-y
Yin, H., Kauffman, K. J., & Anderson, D. G. (2017). Delivery technologies for genome editing. Nature reviews Drug discovery, 16(6), 387-399. DOI: https://doi.org/10.1038/nrd.2016.280
Adli, M. (2018). The CRISPR tool kit for genome editing and beyond. Nature communications, 9(1), 1911. DOI: https://doi.org/10.1038/s41467-018-04252-2
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015). Therapeutic genome editing: prospects and challenges. Nature Medicine, 21(2), 121-131. DOI: https://doi.org/10.1038/nm.3793
Carroll, D. (2017). Focus: genome editing: genome editing: past, present, and future. The Yale journal of biology and medicine, 90(4), 653.
Khan, S. H. (2019). Genome-editing technologies: concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application. Molecular Therapy-Nucleic Acids, 16, 326-334. DOI: https://doi.org/10.1016/j.omtn.2019.02.027
Baylis, F. (2019). Altered inheritance: CRISPR and the ethics of human genome editing. Harvard University Press. DOI: https://doi.org/10.4159/9780674241954
Sas, D. F., & MARTINLAWRENZ, H. (2017). CRISPR-CAS9: THE LATEST FASHION IN DESIGNER BABIES. Ethics & Medicine: An International Journal of Bioethics, 33(2).
Pieczynski, J. N., & Kee, H. L. (2021). “Designer babies?!” A CRISPR‐based learning module for undergraduates built around the CCR5 gene. Biochemistry and Molecular Biology Education, 49(1), 80-93. DOI: https://doi.org/10.1002/bmb.21395
Benston, S. (2017). Everything in moderation, even hype: learning from vaccine controversies to strike a balance with CRISPR. Journal of Medical Ethics, 43(12), 819-823. DOI: https://doi.org/10.1136/medethics-2016-103666
Dickenson, D., & Darnovsky, M. (2019). Did a permissive scientific culture encourage the ‘CRISPR babies’ experiment?. Nature Biotechnology, 37(4), 355-357. DOI: https://doi.org/10.1038/s41587-019-0077-3
Marangi, M., & Pistritto, G. (2018). Innovative therapeutic strategies for cystic fibrosis: moving forward to CRISPR technique. Frontiers in pharmacology, 9, 396. DOI: https://doi.org/10.3389/fphar.2018.00396
Demirci, S., Leonard, A., Haro-Mora, J. J., Uchida, N., & Tisdale, J. F. (2019). CRISPR/Cas9 for sickle cell disease: applications, future possibilities, and challenges. Cell Biology and Translational Medicine, Volume 5: Stem Cells: Translational Science to Therapy, 37-52. DOI: https://doi.org/10.1007/5584_2018_331
Ou, L., Przybilla, M. J., Tăbăran, A. F., Overn, P., O’Sullivan, M. G., Jiang, X., ... & Whitley, C. B. (2020). A novel gene editing system to treat both Tay–Sachs and Sandhoff diseases. Gene therapy, 27(5), 226-236. DOI: https://doi.org/10.1038/s41434-019-0120-5
Kim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017). Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nature Biotechnology, 35(4), 371-376. DOI: https://doi.org/10.1038/nbt.3803
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 533(7603), 420-424. DOI: https://doi.org/10.1038/nature17946
Santamaria, D., & Ortega, S. (2006). Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci, 11(1), 1164-1188. DOI: https://doi.org/10.2741/1871
Kabeer, F., Beverly, L. J., Darrasse-Jèze, G., & Podsypanina, K. (2016). Methods to study metastasis in genetically modified mice. Cold Spring Harbor Protocols, 2016(2), pdb-top069948. DOI: https://doi.org/10.1101/pdb.top069948
Westphalen, C. B., & Olive, K. P. (2012). Genetically engineered mouse models of pancreatic cancer. The Cancer Journal, 18(6), 502-510. DOI: https://doi.org/10.1097/PPO.0b013e31827ab4c4
Brown, R. E. (2022). Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?. The EuroBiotech Journal, 6(2), 61-88. DOI: https://doi.org/10.2478/ebtj-2022-0008
Forabosco, F., Löhmus, M., Rydhmer, L., & Sundström, L. F. (2013). Genetically modified farm animals and fish in agriculture: A review. Livestock Science, 153(1-3), 1-9. DOI: https://doi.org/10.1016/j.livsci.2013.01.002
Sasaki, E. (2015). Prospects for genetically modified non-human primate models, including the common marmoset. Neuroscience research, 93, 110-115. DOI: https://doi.org/10.1016/j.neures.2015.01.011
Regalado, A. (2018). EXCLUSIVE: Chinese scientists are creating CRISPR babies. Technology Review. November, 25.
Greely, H. T. (2019). CRISPR’d babies: human germline genome editing in the ‘He Jiankui affair’. Journal of Law and the Biosciences, 6(1), 111-183. DOI: https://doi.org/10.1093/jlb/lsz010
Normile, D. (2018). Shock greets claim of CRISPR-edited babies. DOI: https://doi.org/10.1126/science.362.6418.978
Krimsky, S. (2019). Ten ways in which He Jiankui violated ethics. Nature Biotechnology, 37(1), 19-20. DOI: https://doi.org/10.1038/nbt.4337
Dobson, R. (2000). " Designer baby" cures sister. BMJ: British Medical Journal, 321(7268), 1040. DOI: https://doi.org/10.1136/bmj.321.7268.1040
Park, A. (2000). Designer Baby. Time, 156(16), 102-102. DOI: https://doi.org/10.1034/j.1600-0447.2000.102002156.x
Bauman, H. D. L. (2005). Designing deaf babies and the question of disability. Journal of Deaf Studies and Deaf Education, 10(3), 311-315. DOI: https://doi.org/10.1093/deafed/eni031
Araki, M., & Ishii, T. (2014). International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reproductive biology and endocrinology, 12(1), 1-12. DOI: https://doi.org/10.1186/1477-7827-12-108
Rosemann, A., Balen, A., Nerlich, B., Hauskeller, C., Sleeboom‐Faulkner, M., Hartley, S., ... & Lee, N. (2019). Heritable genome editing in a global context: national and international policy challenges. Hastings Center Report, 49(3), 30-42. DOI: https://doi.org/10.1002/hast.1006
Castro, R. J. (2016). Mitochondrial replacement therapy: the UK and US regulatory landscapes. Journal of Law and the Biosciences, 3(3), 726-735. DOI: https://doi.org/10.1093/jlb/lsw051
Sanjay, S., & Prasath, N. H. Designer Babies: Revealing the Ethical and Social Implications of Genetic Engineering in Human Embryos.
Nicol, D., Rudge, C., Paxton, R., & Niemeyer, S. (2022). How should we regulate heritable human genome editing in Australia?. Journal of Law & Medicine, 29(2).
De Miguel Beriain, I. (2017). Legal issues regarding gene editing at the beginning of life: an EU perspective. Regenerative Medicine, 12(6), 669-679. DOI: https://doi.org/10.2217/rme-2017-0033
Li, G., Liu, Y. G., & Chen, Y. (2019). Genome-editing technologies: the gap between application and policy. Sci China Life Sci, 62, 1534-1538. DOI: https://doi.org/10.1007/s11427-019-1566-1